Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

Think back to the last time you jotted down a quick note or made a grocery list. Chances are, it wasn’t with pen and paper. Over the past decade, keyboards and screens have quietly replaced ...